Abbott Laboratories flatly denied an Aug. 27 media report that it planned to acquire St. Jude Medical for billions of dollars.
The Financial Times reported at day's start that Abbott was raising money in preparation for a $25 billion bid for the cardiovascular and neurovascular device firm, but Abbott was quick...